SynapDx Taps Into Funding From Google For Autism Testing
SynapDX, which is developing blood test to enable diagnosis of Autism Spectrum Disorders (ASD), has raised $15.4M in funding, led by Google Ventures. According to SynapDx, the funding also included North Bridge Venture Partners and General Catalyst Partners. SynapDX said its test is aimed at diagnosing pediatric neurodevelopmental disorders. Google's Andrew COnrad, Ph.D., joins the company's board of directors with the funding. SynapDx is based in Lexington, Mass.
posted on Monday, July 22, 2013 (Link to more information)
Related companies:
SynapDx
Related stories:
> Optimus Outcome Buys Autism Acumen
> Google Acquires GraphicsFuzz
> Benchmark Taps Google For EIRs
> Google Launches Phone Payments App
> Kadiant Raises $300M For Autism Spectrum Disorder Support
silicontap.com Home